Uterine fibroids are frequently found incidentally during a routine pelvic exam. There's no single best approach to uterine fibroid treatment — many treatment options exist.
This report contains market size and forecasts of Uterine Fibroids Treatment in Global, including the following market information:
Global Uterine Fibroids Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Uterine Fibroids Treatment market was valued at 159.3 million in 2021 and is projected to reach US$ 199.3 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Endometrial Ablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Uterine Fibroids Treatment include Blue Endo, Boston Scientific Corporation, Cooper Surgical, Acessa Health, Inc., Karl Storz, LiNA Medical, Merit Medical Systems and Olympus Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uterine Fibroids Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uterine Fibroids Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Uterine Fibroids Treatment Market Segment Percentages, by Type, 2021 (%)
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others
Global Uterine Fibroids Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Uterine Fibroids Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Uterine Fibroids Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Uterine Fibroids Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Uterine Fibroids Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Uterine Fibroids Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Blue Endo
Boston Scientific Corporation
Cooper Surgical
Acessa Health, Inc.
Karl Storz
LiNA Medical
Merit Medical Systems
Olympus Corporation